Nephrology Month in Review: April 2024
This month in review highlights top coverage of the latest news in nephrology, ranging from new clinical trial data in IgAN to research about kidney disease management.
Source: hcplive.com
Mayer Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mayer Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mayer Professor Today - Breaking & Trending Today
Jonathan Barratt, MD: Atacicept Could 'Transform How We Think About Treating IgA Nephropathy'
Barratt explained findings from the phase 2b ORIGIN trial of atacicept and how it compares to current standard therapies in IgAN and other agents in the pipeline.
Source: hcplive.com
Updated Clinical Data for Povetacicept in IgA Nephropathy Support Advancement to Phase 3 Trial
RUBY-3 findings support povetacicept’s ability to induce remission, reduce UPCR, stabilize renal function, and resolve hematuria in patients with IgAN.
Source: hcplive.com
Socioeconomically Deprived Patients with IgAN Face Worse Kidney Outcomes
Results highlighted an association between socioeconomic deprivation and greater risk of progression to kidney failure in patients with IgAN.
Source: hcplive.com
Preliminary Data from SPARTAN Trial Presented at ASN 2023
Preliminary data from the SPARTAN study were presented at ASN Kidney Week 2023, demonstrating sparsentan’s impact on proteinuria and total body water over time.
Source: hcplive.com